Hopkins Named President of Gates Vascular Institute

Updated: 2/28/2013

L. Nelson Hopkins, III, MD, has been appointed President of the Gates Vascular Institute.

The Gates Vascular Institute is a team of researchers, surgeons, physicians, and other clinicians devoted to the study, treatment, and prevention of cardiac, stroke, and vascular diseases.

An internationally known neurosurgeon, Dr. Hopkins currently serves as Chief of Neurosurgery for Kaleida Health, Professor and Chairman of Neurosurgery for the University at Buffalo (UB) and CEO of the Jacobs Institute.

Dr. Hopkins' work across these three fronts - clinical, academic and research - led to his appointment as the founding president of the Gates Vascular Institute, a Kaleida Health facility.  The Gates Vascular Institute's success and growth since its opening in March 2012 has driven a need for a new leader to focus on this service line.

Dr. Hopkins will be fully integrated with Cheryl Klass, her team and the three divisions at the Buffalo General Medical Center/Gates Vascular Institute.  Administrative and medical leadership will be focused on two other areas on the medical campus, including orthopedics and medical/surgical/critical care at the Buffalo General Medical Center.  Identification of new leadership for those two key service lines is currently underway.

Dr. Hopkins has spent years working with his UB Neurosurgery team to build the Gates Stroke Center and Kaleida Health neurosurgery program into a destination of choice for world-class stroke and neurosurgery care.

Patients come to the Gates Vascular Institute from around the world for treatments that, oftentimes, only a handful of U.S. hospitals provide, such as the pipeline embolization device procedure for brain aneurysms.

Dr. Hopkins was a driving force behind the creation of Gates Vascular Institute.  This new facility brings together Kaleida Health physicians, UB researchers and our partners at ECMC in a collaborative effort to deliver state-of-the-art clinical care, produce major breakthroughs on the causes and treatment of vascular disease and spin-off new medical and biotechnology businesses and jobs.

In addition to housing Kaleida Health's $173 million merger of its cardiac, stroke and vascular operations, plus a new and expanded emergency department, the building also houses the Jacobs Institute, and UB's $118 million Clinical and Translational Research Center (CTRC) and a UB Biosciences Incubator.

The clinicians at the Gates Vascular Institute are uniquely positioned to provide patient care in a way never before seen in Western New York.  Instead of the traditional "silo approach" to practicing medicine, physicians work side-by-side with their colleagues and researchers in these three disciplines to deliver state-of-the-art care and produce major breakthroughs on the causes and treatments of cardiac, stroke and vascular disease.

Dr. Hopkins' talent and wide-ranging expertise is widely recognized.  In addition to engagements throughout the U.S., Hopkins has spoken at more than 440 international medical conferences and symposiums in countries including: China, Germany, England, India, Austria, France, Columbia, Yugoslavia, Switzerland, Bermuda, Japan, Australia, Mexico, Spain, Ireland, Brazil, Puerto Rico, Panama, Italy, South Africa, Turkey, Monaco, Argentina, and Canada.  He was recently named a SUNY distinguished professor.

Dr. Hopkins has been the recipient of several prestigious local and national honors and awards, and has been a visiting professor at dozens of universities and healthcare facilities including: Cleveland Clinic, Johns Hopkins University, Cedar Sinai Medical Center, Mayo Clinic, Barrow Neurological Institute, and Cornell University, just to name a few.

He has authored, co-authored, or edited more than 400 chapters and journal articles, received more than $30 million in research grants, participated in approximately 50 clinical trials, and currently holds memberships in more than 30 national healthcare organizations.

Dr. Hopkins will report to Jim Kaskie and continue to chair the physician-led board of the Gates Vascular Institute.